Feasibility of next-generation sequencing (Oncomine ™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients
ConclusionsTissue size and tumour cell content were significantly associated with the success rate of Oncomine ™ Dx Target Test companion diagnostics.
Source: Japanese Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Genetics | Japan Health | Lung Cancer | Non-Small Cell Lung Cancer | Sarcomas